ITEM 7.01 REGULATION FD DISCLOSURE

On January 12, 2021, we issued a press release announcing the initiation of a pivotal trial for CLR 131 in Waldenstrom's macroglobulinemia (WM). A copy of the press release is furnished as Exhibit 99.1 and is incorporated by reference herein.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS






(d) Exhibits



   Number       Title
    99.1          Press release dated January 12, 2021, titled "Cellectar
                Initiates Pivotal Trial of CLR 131in Waldenstrom's
                Macroglobulinemia"




                                       2

© Edgar Online, source Glimpses